(Q45400969)

English

Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge (English)

1 reference

Europe PubMed Central

14 December 2017

1 reference

based on heuristic

inferred from title

Newcastle disease

1 reference

based on heuristic

inferred from title

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

based on heuristic

inferred from title

Claudio L Afonso

3

object named as

Claudio L Afonso

1 reference

Europe PubMed Central

14 December 2017

author name string

Patti J Miller

1

1 reference

Europe PubMed Central

14 December 2017

Daniel J King

2

1 reference

Europe PubMed Central

14 December 2017

David L Suarez

4

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

3 August 2007

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

25

1 reference

Europe PubMed Central

14 December 2017

41

1 reference

Europe PubMed Central

14 December 2017

7238-7246

1 reference

Europe PubMed Central

14 December 2017

A summary of taxonomic changes recently approved by ICTV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

The avian response to Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Newcastle disease outbreaks in domestic fowl and turkeys in Great Britain during 1997

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Identification and grouping of Newcastle disease virus strains by restriction site analysis of a region from the F gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Ne

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Efficacy of a commercial Newcastle vaccine against velogenic viscerotropic Newcastle disease virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Comparative efficacy of the B-1 and VG/GA vaccine strains against velogenic viscerotropic Newcastle disease virus in chickens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Antigenic differences among strains of Newcastle disease virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Avian paramyxovirus type 1 from pigeons: isolate characterization and pathogenicity after chicken or embryo passage of selected isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Characterization of class I Newcastle disease virus isolates from Hong Kong live bird markets and detection using real-time reverse transcription-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Experimental pathogenesis for chickens, turkeys, and pigeons of exotic Newcastle disease virus from an outbreak in California during 2002-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Virulence of pigeon-origin Newcastle disease virus isolates for domestic chickens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Oral Newcastle disease vaccination with V4 virus in chickens: comparison with other routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Influence of formulation on the efficacy of experimental oil-emulsion Newcastle disease vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Influence of chicken breed on pathogenicity evaluation of velogenic neurotropic Newcastle disease virus isolates from cormorants and turkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Pathogenesis of chicken-passaged Newcastle disease viruses isolated from chickens and wild and exotic birds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Effect of probe-site mismatches on detection of virulent Newcastle disease viruses using a fusion-gene real-time reverse transcription polymerase chain reaction test.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Rapid and sensitive protein similarity searches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

PHYML Online--a web server for fast maximum likelihood-based phylogenetic inference

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

A fowlpox virus vaccine vector with insertion sites in the terminal repeats: demonstration of its efficacy using the fusion gene of Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North America.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Protective immunity against avian influenza induced by a fowlpox virus recombinant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Molecular evolution of the Newcastle disease virus matrix protein gene and phylogenetic relationships among the paramyxoviridae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.017

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.07.017

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45400969&oldid=2076612675"